These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34314397)

  • 21. Necrobiotic xanthogranuloma: response to chlorambucil.
    Ryan E; Warren LJ; Szabo F
    Australas J Dermatol; 2012 May; 53(2):e23-5. PubMed ID: 22571578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disseminated necrobiotic xanthogranuloma].
    Klingner M; Hansel G; Schönlebe J; Wollina U
    Hautarzt; 2016 Nov; 67(11):902-906. PubMed ID: 27380383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrobiotic xanthogranuloma with giant cell hepatitis, successfully treated with intravenous immunoglobulins.
    Pedrosa AF; Ferreira O; Calistru A; Mota A; Baudrier T; Sarmento JA; Bettencourt H; Azevedo F
    Dermatol Ther; 2015; 28(2):68-70. PubMed ID: 25650024
    [No Abstract]   [Full Text] [Related]  

  • 24. Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with Waldenström macroglobulinemia.
    Balagula Y; Straus DJ; Pulitzer MP; Lacouture ME
    J Clin Oncol; 2011 Apr; 29(11):e305-7. PubMed ID: 21245419
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of necrobiotic xanthogranuloma - a systematic review.
    Miguel D; Lukacs J; Illing T; Elsner P
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periocular Necrobiotic Xanthogranuloma-A Case of Unseen Eyes.
    Desai A; Singh P; Sen S
    JAMA Ophthalmol; 2020 Aug; 138(8):e194778. PubMed ID: 32789521
    [No Abstract]   [Full Text] [Related]  

  • 27. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necrobiotic xanthogranuloma: response to dapsone.
    Wei YH; Cheng JJ; Wu YH; Liu CY; Hung CJ; Hsu JD; Hsiao YP
    Dermatol Ther; 2015; 28(1):7-9. PubMed ID: 25314033
    [No Abstract]   [Full Text] [Related]  

  • 29. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrobiotic Xanthogranuloma as the Presenting Manifestation of Smouldering Myeloma.
    Makkar N; Niyas VKM; Swain S; Sethi P; Nischal N; Agarwal S; Ramam M; Wig N
    J Assoc Physicians India; 2019 Mar; 67(3):87-88. PubMed ID: 31304718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Dermatology: Necrobiotic Xanthogranuloma.
    González-López MA; González-Vela MC
    J Cutan Med Surg; 2021; 25(6):644. PubMed ID: 32726147
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of adult-onset asthma with periocular xanthogranulomas.
    Agi CU; Gober MD; Ferenczi K; Takach P; Eagle RC; Rosenbach M
    Arch Dermatol; 2011 Oct; 147(10):1230-1. PubMed ID: 22006151
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunomodulatory drugs for the treatment of periorbital necrobiotic xanthogranuloma.
    Abdul-Hay M
    Clin Adv Hematol Oncol; 2013 Oct; 11(10):680-1. PubMed ID: 24518383
    [No Abstract]   [Full Text] [Related]  

  • 34. A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma.
    AlGain M; Szalat R; Vignon-Pennamen MD; Malphettes M; Vignon M; de Masson A; Bagot M; Rybojad M; Asli B; Arnulf B; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e3-e5. PubMed ID: 26810089
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcutaneous nodules in an elderly patient. Necrobiotic xanthogranuloma.
    Fu T; Zwerner J; Kim J; Tang J
    Arch Dermatol; 2011 Oct; 147(10):1215-20. PubMed ID: 22006142
    [No Abstract]   [Full Text] [Related]  

  • 36. Necrobiotic xanthogranuloma associated with monoclonal gammopathy of unknown significance.
    Melguizo Moya I; Navarro Puerto MA; Grilo Reina A
    Med Clin (Barc); 2017 Dec; 149(11):509-510. PubMed ID: 28736067
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
    Steinhelfer L; Kühnel T; Jägle H; Mayer S; Karrer S; Haubner F; Schreml S
    Orphanet J Rare Dis; 2022 Mar; 17(1):132. PubMed ID: 35331271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.
    Ghiasi N; Alavi A; Coutts PM; Ghazarian D; Sibbald RG
    Int J Low Extrem Wounds; 2012 Dec; 11(4):293-5. PubMed ID: 23222162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Necrobiotic xanthogranuloma treated with lenalidomide.
    Mahendran P; Wee J; Chong H; Natkunarajah J
    Clin Exp Dermatol; 2018 Apr; 43(3):345-347. PubMed ID: 29048134
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    Gonzales JA; Haemel A; Gross AJ; Acharya NR
    J Ocul Pharmacol Ther; 2017 May; 33(4):325-333. PubMed ID: 28394239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.